Literature DB >> 7426183

Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.

W R Ginks, D R Redwood.   

Abstract

The administration of vasodilator drugs has been shown to have beneficial effects at rest in patients with acute or chronic heart failure. To determine the efficacy of hydralazine during exercise, 10 severely symptomatic patients with chronic left ventricular failure from diffuse coronary disease or cardiomyopathy were studied at rest and during upright exercise on a bicycle ergometer. All patients were already receiving optimal treatment with digitalis and diuretics. At rest treatment with hydralazine resulted in a fall in both mean arterial and pulmonary wedge pressure. There was a 50 per cent reduction in systemic vascular resistance compared with pretreatment measurements and there was an equally impressive increase in stroke volume index. During exertion the changes noted at rest were sustained though occurred to a lesser degree; thus there was a 20 per cent fall in arterial resistance and a 20 per cent rise in stroke volume index compared with control. These findings show that hydralazine administration not only results in a beneficial effect on cardiac function at rest but that this effect is maintained during upright exercise in patients with impaired left ventricular function, thus providing further support for its use in the long-term management of such patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426183      PMCID: PMC482395          DOI: 10.1136/hrt.44.3.259

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK & F 24260 on the redistribution of cardiac output in anaesthetized rabbits.

Authors:  B M Johnson
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

2.  Improved left ventricular function during nitroprusside infusion in acute myocardial infarction.

Authors:  J A Franciosa; C J Limas; N H Guiha; E Rodriguera; J N Cohn
Journal:  Lancet       Date:  1972-03-25       Impact factor: 79.321

3.  Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

Authors:  K Chatterjee; W W Parmley; H J Swan; G Berman; J Forrester; H S Marcus
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

4.  Treatment of refractory heart failure with infusion of nitroprusside.

Authors:  N H Guiha; J N Cohn; E Mikulic; J A Franciosa; C J Limas
Journal:  N Engl J Med       Date:  1974-09-19       Impact factor: 91.245

5.  Hemodynamic and metabolic responses to vasodilator therapy in acute myocardial infarction.

Authors:  K Chatterjee; W W Parmley; W Ganz; J Forrester; P Walinsky; C Crexells; H J Swan
Journal:  Circulation       Date:  1973-12       Impact factor: 29.690

6.  The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm.

Authors:  D T Mason; E Braunwald
Journal:  Circulation       Date:  1965-11       Impact factor: 29.690

7.  Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.

Authors:  R R Miller; L A Vismara; R Zelis; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

8.  Vasodilator therapy in acute myocardial infarction. A comparison of sodium nitroprusside and nitroglycerin.

Authors:  P W Armstrong; D C Walker; J R Burton; J O Parker
Journal:  Circulation       Date:  1975-12       Impact factor: 29.690

9.  Hemodynamic effects of nitroglycerin in acute myocardial infarction.

Authors:  D O Williams; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1975-03       Impact factor: 29.690

10.  A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure.

Authors:  R Zelis; D T Mason; E Braunwald
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

View more
  1 in total

Review 1.  Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors:  J P Mulrow; M H Crawford
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.